company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,,2011-06-30,2011-08-09 16:14:30+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,23506000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,,2011-06-30,2011-08-09 16:14:30+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,5205000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,,2011-06-30,2011-08-09 16:14:30+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,30099000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,,2011-06-30,2011-08-09 16:14:30+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,29725000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,,2011-06-30,2011-08-09 16:14:30+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,13616000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,,2011-06-30,2011-08-09 16:14:30+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,13145000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,,2011-06-30,2011-08-09 16:14:30+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,7848000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,,2011-06-30,2011-08-09 16:14:30+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,123144000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,,2011-06-30,2011-08-09 16:14:30+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,162189000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,,2011-06-30,2011-08-09 16:14:30+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,956000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,,2011-06-30,2011-08-09 16:14:30+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,18146000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,,2011-06-30,2011-08-09 16:14:30+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,3886000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,,2011-06-30,2011-08-09 16:14:30+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,1875000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,,2011-06-30,2011-08-09 16:14:30+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1092000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,,2011-06-30,2011-08-09 16:14:30+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,25955000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,,2011-06-30,2011-08-09 16:14:30+00:00,,totalassets,Total Assets,=,debit,usd,311288000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,,2011-06-30,2011-08-09 16:14:30+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,6639000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,,2011-06-30,2011-08-09 16:14:30+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,26917000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,,2011-06-30,2011-08-09 16:14:30+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,4765000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,,2011-06-30,2011-08-09 16:14:30+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,9109000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,,2011-06-30,2011-08-09 16:14:30+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,811000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,,2011-06-30,2011-08-09 16:14:30+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,48241000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,,2011-06-30,2011-08-09 16:14:30+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,3005000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,,2011-06-30,2011-08-09 16:14:30+00:00,totalnoncurrentliabilities,assetretirementandlitigationobligation,Asset Retirement Reserve & Litigation Obligation,+,credit,usd,1362000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,,2011-06-30,2011-08-09 16:14:30+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,6184000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,,2011-06-30,2011-08-09 16:14:30+00:00,totalnoncurrentliabilities,noncurrentemployeebenefitliabilities,Noncurrent Employee Benefit Liabilities,+,credit,usd,6259000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,,2011-06-30,2011-08-09 16:14:30+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,16810000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,,2011-06-30,2011-08-09 16:14:30+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,65051000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,,2011-06-30,2011-08-09 16:14:30+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,,2011-06-30,2011-08-09 16:14:30+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,205303000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,,2011-06-30,2011-08-09 16:14:30+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,109215000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,,2011-06-30,2011-08-09 16:14:30+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-66888000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,,2011-06-30,2011-08-09 16:14:30+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-1393000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,,2011-06-30,2011-08-09 16:14:30+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,246237000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,,2011-06-30,2011-08-09 16:14:30+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,246237000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,,2011-06-30,2011-08-09 16:14:30+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,246237000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,,2011-06-30,2011-08-09 16:14:30+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,311288000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,,2011-09-30,2011-11-09 16:36:46+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,17498000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,,2011-09-30,2011-11-09 16:36:46+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,2526000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,,2011-09-30,2011-11-09 16:36:46+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,34070000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,,2011-09-30,2011-11-09 16:36:46+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,25135000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,,2011-09-30,2011-11-09 16:36:46+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,14654000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,,2011-09-30,2011-11-09 16:36:46+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,13033000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,,2011-09-30,2011-11-09 16:36:46+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,6456000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,,2011-09-30,2011-11-09 16:36:46+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,113372000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,,2011-09-30,2011-11-09 16:36:46+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,157153000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,,2011-09-30,2011-11-09 16:36:46+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,956000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,,2011-09-30,2011-11-09 16:36:46+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,16407000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,,2011-09-30,2011-11-09 16:36:46+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,3865000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,,2011-09-30,2011-11-09 16:36:46+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,3065000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,,2011-09-30,2011-11-09 16:36:46+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1235000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,,2011-09-30,2011-11-09 16:36:46+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,25528000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,,2011-09-30,2011-11-09 16:36:46+00:00,,totalassets,Total Assets,=,debit,usd,296053000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,,2011-09-30,2011-11-09 16:36:46+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,6239000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,,2011-09-30,2011-11-09 16:36:46+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,25948000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,,2011-09-30,2011-11-09 16:36:46+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,4765000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,,2011-09-30,2011-11-09 16:36:46+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,6757000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,,2011-09-30,2011-11-09 16:36:46+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,296000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,,2011-09-30,2011-11-09 16:36:46+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,44005000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,,2011-09-30,2011-11-09 16:36:46+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,3004000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,,2011-09-30,2011-11-09 16:36:46+00:00,totalnoncurrentliabilities,assetretirementandlitigationobligation,Asset Retirement Reserve & Litigation Obligation,+,credit,usd,1241000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,,2011-09-30,2011-11-09 16:36:46+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,5787000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,,2011-09-30,2011-11-09 16:36:46+00:00,totalnoncurrentliabilities,noncurrentemployeebenefitliabilities,Noncurrent Employee Benefit Liabilities,+,credit,usd,6291000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,,2011-09-30,2011-11-09 16:36:46+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,16323000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,,2011-09-30,2011-11-09 16:36:46+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,60328000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,,2011-09-30,2011-11-09 16:36:46+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,,2011-09-30,2011-11-09 16:36:46+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,206068000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,,2011-09-30,2011-11-09 16:36:46+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,103363000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,,2011-09-30,2011-11-09 16:36:46+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-66888000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,,2011-09-30,2011-11-09 16:36:46+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-6818000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,,2011-09-30,2011-11-09 16:36:46+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,235725000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,,2011-09-30,2011-11-09 16:36:46+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,235725000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,,2011-09-30,2011-11-09 16:36:46+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,235725000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,,2011-09-30,2011-11-09 16:36:46+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,296053000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,,2012-03-31,2012-05-10 13:02:05+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,8244000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,,2012-03-31,2012-05-10 13:02:05+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,4505000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,,2012-03-31,2012-05-10 13:02:05+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,33430000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,,2012-03-31,2012-05-10 13:02:05+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,29308000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,,2012-03-31,2012-05-10 13:02:05+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,12829000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,,2012-03-31,2012-05-10 13:02:05+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,6957000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,,2012-03-31,2012-05-10 13:02:05+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,10673000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,,2012-03-31,2012-05-10 13:02:05+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,105946000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,,2012-03-31,2012-05-10 13:02:05+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,145048000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,,2012-03-31,2012-05-10 13:02:05+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,956000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,,2012-03-31,2012-05-10 13:02:05+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,2992000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,,2012-03-31,2012-05-10 13:02:05+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,6520000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,,2012-03-31,2012-05-10 13:02:05+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1907000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,,2012-03-31,2012-05-10 13:02:05+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,12375000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,,2012-03-31,2012-05-10 13:02:05+00:00,,totalassets,Total Assets,=,debit,usd,263369000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,,2012-03-31,2012-05-10 13:02:05+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,2439000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,,2012-03-31,2012-05-10 13:02:05+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,24997000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,,2012-03-31,2012-05-10 13:02:05+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,3741000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,,2012-03-31,2012-05-10 13:02:05+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,7332000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,,2012-03-31,2012-05-10 13:02:05+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,1523000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,,2012-03-31,2012-05-10 13:02:05+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,40032000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,,2012-03-31,2012-05-10 13:02:05+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,3002000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,,2012-03-31,2012-05-10 13:02:05+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,3929000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,,2012-03-31,2012-05-10 13:02:05+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,749000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,,2012-03-31,2012-05-10 13:02:05+00:00,totalnoncurrentliabilities,noncurrentemployeebenefitliabilities,Noncurrent Employee Benefit Liabilities,+,credit,usd,8765000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,,2012-03-31,2012-05-10 13:02:05+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1544000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,,2012-03-31,2012-05-10 13:02:05+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,17989000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,,2012-03-31,2012-05-10 13:02:05+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,58021000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,,2012-03-31,2012-05-10 13:02:05+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,,2012-03-31,2012-05-10 13:02:05+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,207004000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,,2012-03-31,2012-05-10 13:02:05+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,75147000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,,2012-03-31,2012-05-10 13:02:05+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-66888000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,,2012-03-31,2012-05-10 13:02:05+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-9915000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,,2012-03-31,2012-05-10 13:02:05+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,205348000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,,2012-03-31,2012-05-10 13:02:05+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,205348000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,,2012-03-31,2012-05-10 13:02:05+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,205348000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,,2012-03-31,2012-05-10 13:02:05+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,263369000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,,2012-06-30,2012-08-20 16:54:22+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,13395000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,,2012-06-30,2012-08-20 16:54:22+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,35258000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,,2012-06-30,2012-08-20 16:54:22+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,35879000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,,2012-06-30,2012-08-20 16:54:22+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,10849000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,,2012-06-30,2012-08-20 16:54:22+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,6875000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,,2012-06-30,2012-08-20 16:54:22+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,7005000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,,2012-06-30,2012-08-20 16:54:22+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,109261000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,,2012-06-30,2012-08-20 16:54:22+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,142187000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,,2012-06-30,2012-08-20 16:54:22+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,956000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,,2012-06-30,2012-08-20 16:54:22+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,3062000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,,2012-06-30,2012-08-20 16:54:22+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,5563000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,,2012-06-30,2012-08-20 16:54:22+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1350000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,,2012-06-30,2012-08-20 16:54:22+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,5000000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,,2012-06-30,2012-08-20 16:54:22+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,15931000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,,2012-06-30,2012-08-20 16:54:22+00:00,,totalassets,Total Assets,=,debit,usd,267379000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,,2012-06-30,2012-08-20 16:54:22+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,418000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,,2012-06-30,2012-08-20 16:54:22+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,27979000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,,2012-06-30,2012-08-20 16:54:22+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,3400000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,,2012-06-30,2012-08-20 16:54:22+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,7170000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,,2012-06-30,2012-08-20 16:54:22+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,871000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,,2012-06-30,2012-08-20 16:54:22+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,39838000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,,2012-06-30,2012-08-20 16:54:22+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,7587000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,,2012-06-30,2012-08-20 16:54:22+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,3571000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,,2012-06-30,2012-08-20 16:54:22+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,829000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,,2012-06-30,2012-08-20 16:54:22+00:00,totalnoncurrentliabilities,noncurrentemployeebenefitliabilities,Noncurrent Employee Benefit Liabilities,+,credit,usd,9168000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,,2012-06-30,2012-08-20 16:54:22+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1385000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,,2012-06-30,2012-08-20 16:54:22+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,22540000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,,2012-06-30,2012-08-20 16:54:22+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,62378000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,,2012-06-30,2012-08-20 16:54:22+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,,2012-06-30,2012-08-20 16:54:22+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,207581000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,,2012-06-30,2012-08-20 16:54:22+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,75404000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,,2012-06-30,2012-08-20 16:54:22+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-66888000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,,2012-06-30,2012-08-20 16:54:22+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-11096000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,,2012-06-30,2012-08-20 16:54:22+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,205001000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,,2012-06-30,2012-08-20 16:54:22+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,205001000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,,2012-06-30,2012-08-20 16:54:22+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,205001000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,,2012-06-30,2012-08-20 16:54:22+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,267379000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,,2012-09-30,2012-11-09 12:23:56+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,15673000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,,2012-09-30,2012-11-09 12:23:56+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,35180000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,,2012-09-30,2012-11-09 12:23:56+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,33156000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,,2012-09-30,2012-11-09 12:23:56+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,10885000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,,2012-09-30,2012-11-09 12:23:56+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,3233000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,,2012-09-30,2012-11-09 12:23:56+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,9260000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,,2012-09-30,2012-11-09 12:23:56+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,107387000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,,2012-09-30,2012-11-09 12:23:56+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,141495000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,,2012-09-30,2012-11-09 12:23:56+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,956000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,,2012-09-30,2012-11-09 12:23:56+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,3119000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,,2012-09-30,2012-11-09 12:23:56+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,5117000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,,2012-09-30,2012-11-09 12:23:56+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1393000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,,2012-09-30,2012-11-09 12:23:56+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,5000000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,,2012-09-30,2012-11-09 12:23:56+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,15585000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,,2012-09-30,2012-11-09 12:23:56+00:00,,totalassets,Total Assets,=,debit,usd,264467000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,,2012-09-30,2012-11-09 12:23:56+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,597000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,,2012-09-30,2012-11-09 12:23:56+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,26001000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,,2012-09-30,2012-11-09 12:23:56+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,7205000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,,2012-09-30,2012-11-09 12:23:56+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,1004000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,,2012-09-30,2012-11-09 12:23:56+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,284000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,,2012-09-30,2012-11-09 12:23:56+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,3058000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,,2012-09-30,2012-11-09 12:23:56+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,38149000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,,2012-09-30,2012-11-09 12:23:56+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,7407000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,,2012-09-30,2012-11-09 12:23:56+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,3214000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,,2012-09-30,2012-11-09 12:23:56+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,888000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,,2012-09-30,2012-11-09 12:23:56+00:00,totalnoncurrentliabilities,noncurrentemployeebenefitliabilities,Noncurrent Employee Benefit Liabilities,+,credit,usd,8909000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,,2012-09-30,2012-11-09 12:23:56+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1339000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,,2012-09-30,2012-11-09 12:23:56+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,21757000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,,2012-09-30,2012-11-09 12:23:56+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,59906000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,,2012-09-30,2012-11-09 12:23:56+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,,2012-09-30,2012-11-09 12:23:56+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,208150000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,,2012-09-30,2012-11-09 12:23:56+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,73261000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,,2012-09-30,2012-11-09 12:23:56+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-66888000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,,2012-09-30,2012-11-09 12:23:56+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-9962000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,,2012-09-30,2012-11-09 12:23:56+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,204561000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,,2012-09-30,2012-11-09 12:23:56+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,204561000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,,2012-09-30,2012-11-09 12:23:56+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,204561000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,,2012-09-30,2012-11-09 12:23:56+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,264467000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,,2013-03-31,2013-05-09 16:00:01+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,28535000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,,2013-03-31,2013-05-09 16:00:01+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,1032000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,,2013-03-31,2013-05-09 16:00:01+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,36345000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,,2013-03-31,2013-05-09 16:00:01+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,32763000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,,2013-03-31,2013-05-09 16:00:01+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,10179000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,,2013-03-31,2013-05-09 16:00:01+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,2748000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,,2013-03-31,2013-05-09 16:00:01+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,12978000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,,2013-03-31,2013-05-09 16:00:01+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,124580000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,,2013-03-31,2013-05-09 16:00:01+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,132875000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,,2013-03-31,2013-05-09 16:00:01+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,956000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,,2013-03-31,2013-05-09 16:00:01+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,3075000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,,2013-03-31,2013-05-09 16:00:01+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,2406000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,,2013-03-31,2013-05-09 16:00:01+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1760000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,,2013-03-31,2013-05-09 16:00:01+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,4345000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,,2013-03-31,2013-05-09 16:00:01+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,12542000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,,2013-03-31,2013-05-09 16:00:01+00:00,,totalassets,Total Assets,=,debit,usd,269997000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,,2013-03-31,2013-05-09 16:00:01+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,954000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,,2013-03-31,2013-05-09 16:00:01+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,22102000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,,2013-03-31,2013-05-09 16:00:01+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,8245000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,,2013-03-31,2013-05-09 16:00:01+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,2337000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,,2013-03-31,2013-05-09 16:00:01+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,543000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,,2013-03-31,2013-05-09 16:00:01+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,2376000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,,2013-03-31,2013-05-09 16:00:01+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,36557000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,,2013-03-31,2013-05-09 16:00:01+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,7048000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,,2013-03-31,2013-05-09 16:00:01+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,2500000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,,2013-03-31,2013-05-09 16:00:01+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,781000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,,2013-03-31,2013-05-09 16:00:01+00:00,totalnoncurrentliabilities,noncurrentemployeebenefitliabilities,Noncurrent Employee Benefit Liabilities,+,credit,usd,8495000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,,2013-03-31,2013-05-09 16:00:01+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1040000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,,2013-03-31,2013-05-09 16:00:01+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,19864000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,,2013-03-31,2013-05-09 16:00:01+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,56421000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,,2013-03-31,2013-05-09 16:00:01+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,,2013-03-31,2013-05-09 16:00:01+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,209635000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,,2013-03-31,2013-05-09 16:00:01+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,81682000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,,2013-03-31,2013-05-09 16:00:01+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-66888000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,,2013-03-31,2013-05-09 16:00:01+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-10853000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,,2013-03-31,2013-05-09 16:00:01+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,213576000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,,2013-03-31,2013-05-09 16:00:01+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,213576000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,,2013-03-31,2013-05-09 16:00:01+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,213576000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,,2013-03-31,2013-05-09 16:00:01+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,269997000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,,2013-06-30,2013-08-08 17:12:00+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,37966000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,,2013-06-30,2013-08-08 17:12:00+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,714000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,,2013-06-30,2013-08-08 17:12:00+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,38462000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,,2013-06-30,2013-08-08 17:12:00+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,35297000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,,2013-06-30,2013-08-08 17:12:00+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,8231000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,,2013-06-30,2013-08-08 17:12:00+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,3017000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,,2013-06-30,2013-08-08 17:12:00+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,8530000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,,2013-06-30,2013-08-08 17:12:00+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,132217000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,,2013-06-30,2013-08-08 17:12:00+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,129120000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,,2013-06-30,2013-08-08 17:12:00+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,956000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,,2013-06-30,2013-08-08 17:12:00+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,3131000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,,2013-06-30,2013-08-08 17:12:00+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,2258000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,,2013-06-30,2013-08-08 17:12:00+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1019000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,,2013-06-30,2013-08-08 17:12:00+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,4167000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,,2013-06-30,2013-08-08 17:12:00+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,11531000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,,2013-06-30,2013-08-08 17:12:00+00:00,,totalassets,Total Assets,=,debit,usd,272868000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,,2013-06-30,2013-08-08 17:12:00+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,1024000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,,2013-06-30,2013-08-08 17:12:00+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,28900000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,,2013-06-30,2013-08-08 17:12:00+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,9838000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,,2013-06-30,2013-08-08 17:12:00+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,0.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,,2013-06-30,2013-08-08 17:12:00+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,284000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,,2013-06-30,2013-08-08 17:12:00+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,2034000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,,2013-06-30,2013-08-08 17:12:00+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,42080000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,,2013-06-30,2013-08-08 17:12:00+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,6563000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,,2013-06-30,2013-08-08 17:12:00+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,2143000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,,2013-06-30,2013-08-08 17:12:00+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,835000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,,2013-06-30,2013-08-08 17:12:00+00:00,totalnoncurrentliabilities,noncurrentemployeebenefitliabilities,Noncurrent Employee Benefit Liabilities,+,credit,usd,8559000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,,2013-06-30,2013-08-08 17:12:00+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,2109000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,,2013-06-30,2013-08-08 17:12:00+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,20209000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,,2013-06-30,2013-08-08 17:12:00+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,62289000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,,2013-06-30,2013-08-08 17:12:00+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,,2013-06-30,2013-08-08 17:12:00+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,210816000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,,2013-06-30,2013-08-08 17:12:00+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,79435000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,,2013-06-30,2013-08-08 17:12:00+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-66979000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,,2013-06-30,2013-08-08 17:12:00+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-12693000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,,2013-06-30,2013-08-08 17:12:00+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,210579000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,,2013-06-30,2013-08-08 17:12:00+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,210579000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,,2013-06-30,2013-08-08 17:12:00+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,210579000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,,2013-06-30,2013-08-08 17:12:00+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,272868000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,,2013-09-30,2013-11-08 16:53:00+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,39720000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,,2013-09-30,2013-11-08 16:53:00+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,714000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,,2013-09-30,2013-11-08 16:53:00+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,43691000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,,2013-09-30,2013-11-08 16:53:00+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,34460000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,,2013-09-30,2013-11-08 16:53:00+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,9568000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,,2013-09-30,2013-11-08 16:53:00+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,2450000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,,2013-09-30,2013-11-08 16:53:00+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,7778000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,,2013-09-30,2013-11-08 16:53:00+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,138381000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,,2013-09-30,2013-11-08 16:53:00+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,128369000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,,2013-09-30,2013-11-08 16:53:00+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,956000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,,2013-09-30,2013-11-08 16:53:00+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,3057000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,,2013-09-30,2013-11-08 16:53:00+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,1780000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,,2013-09-30,2013-11-08 16:53:00+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,875000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,,2013-09-30,2013-11-08 16:53:00+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,3988000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,,2013-09-30,2013-11-08 16:53:00+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,10656000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,,2013-09-30,2013-11-08 16:53:00+00:00,,totalassets,Total Assets,=,debit,usd,277406000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,,2013-09-30,2013-11-08 16:53:00+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,1024000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,,2013-09-30,2013-11-08 16:53:00+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,28887000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,,2013-09-30,2013-11-08 16:53:00+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,9668000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,,2013-09-30,2013-11-08 16:53:00+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,1064000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,,2013-09-30,2013-11-08 16:53:00+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,260000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,,2013-09-30,2013-11-08 16:53:00+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,1693000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,,2013-09-30,2013-11-08 16:53:00+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,42596000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,,2013-09-30,2013-11-08 16:53:00+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,6384000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,,2013-09-30,2013-11-08 16:53:00+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,1786000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,,2013-09-30,2013-11-08 16:53:00+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,859000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,,2013-09-30,2013-11-08 16:53:00+00:00,totalnoncurrentliabilities,noncurrentemployeebenefitliabilities,Noncurrent Employee Benefit Liabilities,+,credit,usd,8363000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,,2013-09-30,2013-11-08 16:53:00+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1755000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,,2013-09-30,2013-11-08 16:53:00+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,19147000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,,2013-09-30,2013-11-08 16:53:00+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,61743000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,,2013-09-30,2013-11-08 16:53:00+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,,2013-09-30,2013-11-08 16:53:00+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,212149000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,,2013-09-30,2013-11-08 16:53:00+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,83365000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,,2013-09-30,2013-11-08 16:53:00+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-67045000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,,2013-09-30,2013-11-08 16:53:00+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-12806000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,,2013-09-30,2013-11-08 16:53:00+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,215663000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,,2013-09-30,2013-11-08 16:53:00+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,215663000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,,2013-09-30,2013-11-08 16:53:00+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,215663000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,,2013-09-30,2013-11-08 16:53:00+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,277406000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,,2014-03-31,2014-05-09 14:52:12+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,166623000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,,2014-03-31,2014-05-09 14:52:12+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,714000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,,2014-03-31,2014-05-09 14:52:12+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,58111000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,,2014-03-31,2014-05-09 14:52:12+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,35279000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,,2014-03-31,2014-05-09 14:52:12+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,8308000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,,2014-03-31,2014-05-09 14:52:12+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,3017000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,,2014-03-31,2014-05-09 14:52:12+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,8367000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,,2014-03-31,2014-05-09 14:52:12+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,280419000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,,2014-03-31,2014-05-09 14:52:12+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,127365000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,,2014-03-31,2014-05-09 14:52:12+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,3033000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,,2014-03-31,2014-05-09 14:52:12+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,1452000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,,2014-03-31,2014-05-09 14:52:12+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,85591000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,,2014-03-31,2014-05-09 14:52:12+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,3631000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,,2014-03-31,2014-05-09 14:52:12+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,93707000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,,2014-03-31,2014-05-09 14:52:12+00:00,,totalassets,Total Assets,=,debit,usd,501491000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,,2014-03-31,2014-05-09 14:52:12+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,1024000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,,2014-03-31,2014-05-09 14:52:12+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,26855000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,,2014-03-31,2014-05-09 14:52:12+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,7319000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,,2014-03-31,2014-05-09 14:52:12+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,1671000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,,2014-03-31,2014-05-09 14:52:12+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,847000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,,2014-03-31,2014-05-09 14:52:12+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,1351000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,,2014-03-31,2014-05-09 14:52:12+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,39067000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,,2014-03-31,2014-05-09 14:52:12+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,124349000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,,2014-03-31,2014-05-09 14:52:12+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,1444000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,,2014-03-31,2014-05-09 14:52:12+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,632000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,,2014-03-31,2014-05-09 14:52:12+00:00,totalnoncurrentliabilities,noncurrentemployeebenefitliabilities,Noncurrent Employee Benefit Liabilities,+,credit,usd,4535000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,,2014-03-31,2014-05-09 14:52:12+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,78933000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,,2014-03-31,2014-05-09 14:52:12+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,209893000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,,2014-03-31,2014-05-09 14:52:12+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,248960000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,,2014-03-31,2014-05-09 14:52:12+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,,2014-03-31,2014-05-09 14:52:12+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,,2014-03-31,2014-05-09 14:52:12+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,239088000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,,2014-03-31,2014-05-09 14:52:12+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,91357000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,,2014-03-31,2014-05-09 14:52:12+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-67366000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,,2014-03-31,2014-05-09 14:52:12+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-10548000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,,2014-03-31,2014-05-09 14:52:12+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,252531000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,,2014-03-31,2014-05-09 14:52:12+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,252531000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,,2014-03-31,2014-05-09 14:52:12+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,252531000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,,2014-03-31,2014-05-09 14:52:12+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,501491000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,,2014-06-30,2014-08-11 16:27:38+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,130417000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,,2014-06-30,2014-08-11 16:27:38+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,6467000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,,2014-06-30,2014-08-11 16:27:38+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,58480000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,,2014-06-30,2014-08-11 16:27:38+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,44277000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,,2014-06-30,2014-08-11 16:27:38+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,10325000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,,2014-06-30,2014-08-11 16:27:38+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,4311000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,,2014-06-30,2014-08-11 16:27:38+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,6541000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,,2014-06-30,2014-08-11 16:27:38+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,260818000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,,2014-06-30,2014-08-11 16:27:38+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,131619000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,,2014-06-30,2014-08-11 16:27:38+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,16866000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,,2014-06-30,2014-08-11 16:27:38+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,15348000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,,2014-06-30,2014-08-11 16:27:38+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,1876000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,,2014-06-30,2014-08-11 16:27:38+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,93623000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,,2014-06-30,2014-08-11 16:27:38+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,0.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,,2014-06-30,2014-08-11 16:27:38+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,127713000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,,2014-06-30,2014-08-11 16:27:38+00:00,,totalassets,Total Assets,=,debit,usd,520150000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,,2014-06-30,2014-08-11 16:27:38+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,406000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,,2014-06-30,2014-08-11 16:27:38+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,32685000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,,2014-06-30,2014-08-11 16:27:38+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,9038000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,,2014-06-30,2014-08-11 16:27:38+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,6651000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,,2014-06-30,2014-08-11 16:27:38+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,681000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,,2014-06-30,2014-08-11 16:27:38+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,669000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,,2014-06-30,2014-08-11 16:27:38+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,50130000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,,2014-06-30,2014-08-11 16:27:38+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,122154000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,,2014-06-30,2014-08-11 16:27:38+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,975000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,,2014-06-30,2014-08-11 16:27:38+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,71000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,,2014-06-30,2014-08-11 16:27:38+00:00,totalnoncurrentliabilities,noncurrentemployeebenefitliabilities,Noncurrent Employee Benefit Liabilities,+,credit,usd,4474000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,,2014-06-30,2014-08-11 16:27:38+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,89035000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,,2014-06-30,2014-08-11 16:27:38+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,216709000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,,2014-06-30,2014-08-11 16:27:38+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,266839000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,,2014-06-30,2014-08-11 16:27:38+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,,2014-06-30,2014-08-11 16:27:38+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,240734000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,,2014-06-30,2014-08-11 16:27:38+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,90134000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,,2014-06-30,2014-08-11 16:27:38+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-67474000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,,2014-06-30,2014-08-11 16:27:38+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-10083000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,,2014-06-30,2014-08-11 16:27:38+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,253311000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,,2014-06-30,2014-08-11 16:27:38+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,253311000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,,2014-06-30,2014-08-11 16:27:38+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,253311000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,,2014-06-30,2014-08-11 16:27:38+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,520150000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,,2014-09-30,2014-11-10 17:23:15+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,18416000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,,2014-09-30,2014-11-10 17:23:15+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,5483000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,,2014-09-30,2014-11-10 17:23:15+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,56205000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,,2014-09-30,2014-11-10 17:23:15+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,56020000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,,2014-09-30,2014-11-10 17:23:15+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,13235000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,,2014-09-30,2014-11-10 17:23:15+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,4630000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,,2014-09-30,2014-11-10 17:23:15+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,4987000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,,2014-09-30,2014-11-10 17:23:15+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,158976000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,,2014-09-30,2014-11-10 17:23:15+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,165926000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,,2014-09-30,2014-11-10 17:23:15+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,62047000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,,2014-09-30,2014-11-10 17:23:15+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,35455000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,,2014-09-30,2014-11-10 17:23:15+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,2377000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,,2014-09-30,2014-11-10 17:23:15+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,108255000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,,2014-09-30,2014-11-10 17:23:15+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,0.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,,2014-09-30,2014-11-10 17:23:15+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,208134000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,,2014-09-30,2014-11-10 17:23:15+00:00,,totalassets,Total Assets,=,debit,usd,533036000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,,2014-09-30,2014-11-10 17:23:15+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,407000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,,2014-09-30,2014-11-10 17:23:15+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,41081000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,,2014-09-30,2014-11-10 17:23:15+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,11931000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,,2014-09-30,2014-11-10 17:23:15+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,0.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,,2014-09-30,2014-11-10 17:23:15+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,546000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,,2014-09-30,2014-11-10 17:23:15+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,669000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,,2014-09-30,2014-11-10 17:23:15+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,54634000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,,2014-09-30,2014-11-10 17:23:15+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,123571000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,,2014-09-30,2014-11-10 17:23:15+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,480000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,,2014-09-30,2014-11-10 17:23:15+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,0.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,,2014-09-30,2014-11-10 17:23:15+00:00,totalnoncurrentliabilities,noncurrentemployeebenefitliabilities,Noncurrent Employee Benefit Liabilities,+,credit,usd,4318000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,,2014-09-30,2014-11-10 17:23:15+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,104834000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,,2014-09-30,2014-11-10 17:23:15+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,233203000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,,2014-09-30,2014-11-10 17:23:15+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,287837000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,,2014-09-30,2014-11-10 17:23:15+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,,2014-09-30,2014-11-10 17:23:15+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,,2014-09-30,2014-11-10 17:23:15+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,242745000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,,2014-09-30,2014-11-10 17:23:15+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,81493000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,,2014-09-30,2014-11-10 17:23:15+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-67593000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,,2014-09-30,2014-11-10 17:23:15+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-11446000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,,2014-09-30,2014-11-10 17:23:15+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,245199000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,,2014-09-30,2014-11-10 17:23:15+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,245199000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,,2014-09-30,2014-11-10 17:23:15+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,245199000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,,2014-09-30,2014-11-10 17:23:15+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,533036000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,,2015-03-31,2015-05-08 15:47:42+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,28515000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,,2015-03-31,2015-05-08 15:47:42+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,3675000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,,2015-03-31,2015-05-08 15:47:42+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,78432000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,,2015-03-31,2015-05-08 15:47:42+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,53504000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,,2015-03-31,2015-05-08 15:47:42+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,12957000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,,2015-03-31,2015-05-08 15:47:42+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,4777000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,,2015-03-31,2015-05-08 15:47:42+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,7911000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,,2015-03-31,2015-05-08 15:47:42+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,189771000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,,2015-03-31,2015-05-08 15:47:42+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,176997000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,,2015-03-31,2015-05-08 15:47:42+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,92859000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,,2015-03-31,2015-05-08 15:47:42+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,39966000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,,2015-03-31,2015-05-08 15:47:42+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,1041000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,,2015-03-31,2015-05-08 15:47:42+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,70508000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,,2015-03-31,2015-05-08 15:47:42+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,204374000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,,2015-03-31,2015-05-08 15:47:42+00:00,,totalassets,Total Assets,=,debit,usd,571142000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,,2015-03-31,2015-05-08 15:47:42+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,413000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,,2015-03-31,2015-05-08 15:47:42+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,42844000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,,2015-03-31,2015-05-08 15:47:42+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,9848000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,,2015-03-31,2015-05-08 15:47:42+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,0.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,,2015-03-31,2015-05-08 15:47:42+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,651000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,,2015-03-31,2015-05-08 15:47:42+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,0.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,,2015-03-31,2015-05-08 15:47:42+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,53756000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,,2015-03-31,2015-05-08 15:47:42+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,200493000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,,2015-03-31,2015-05-08 15:47:42+00:00,totalnoncurrentliabilities,noncurrentemployeebenefitliabilities,Noncurrent Employee Benefit Liabilities,+,credit,usd,7941000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,,2015-03-31,2015-05-08 15:47:42+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,67077000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,,2015-03-31,2015-05-08 15:47:42+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,275511000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,,2015-03-31,2015-05-08 15:47:42+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,329267000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,,2015-03-31,2015-05-08 15:47:42+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,,2015-03-31,2015-05-08 15:47:42+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,,2015-03-31,2015-05-08 15:47:42+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,248000000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,,2015-03-31,2015-05-08 15:47:42+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,77409000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,,2015-03-31,2015-05-08 15:47:42+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-68108000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,,2015-03-31,2015-05-08 15:47:42+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-15426000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,,2015-03-31,2015-05-08 15:47:42+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,241875000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,,2015-03-31,2015-05-08 15:47:42+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,241875000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,,2015-03-31,2015-05-08 15:47:42+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,241875000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,,2015-03-31,2015-05-08 15:47:42+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,571142000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,,2015-06-30,2015-08-07 16:23:04+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,42556000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,,2015-06-30,2015-08-07 16:23:04+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,3000000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,,2015-06-30,2015-08-07 16:23:04+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,79068000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,,2015-06-30,2015-08-07 16:23:04+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,60605000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,,2015-06-30,2015-08-07 16:23:04+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,11281000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,,2015-06-30,2015-08-07 16:23:04+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,4575000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,,2015-06-30,2015-08-07 16:23:04+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,5582000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,,2015-06-30,2015-08-07 16:23:04+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,206667000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,,2015-06-30,2015-08-07 16:23:04+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,175045000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,,2015-06-30,2015-08-07 16:23:04+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,94044000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,,2015-06-30,2015-08-07 16:23:04+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,39563000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,,2015-06-30,2015-08-07 16:23:04+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,1220000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,,2015-06-30,2015-08-07 16:23:04+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,86045000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,,2015-06-30,2015-08-07 16:23:04+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,220872000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,,2015-06-30,2015-08-07 16:23:04+00:00,,totalassets,Total Assets,=,debit,usd,602584000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,,2015-06-30,2015-08-07 16:23:04+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,455000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,,2015-06-30,2015-08-07 16:23:04+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,49503000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,,2015-06-30,2015-08-07 16:23:04+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,10092000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,,2015-06-30,2015-08-07 16:23:04+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,0.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,,2015-06-30,2015-08-07 16:23:04+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,509000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,,2015-06-30,2015-08-07 16:23:04+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,0.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,,2015-06-30,2015-08-07 16:23:04+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,60559000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,,2015-06-30,2015-08-07 16:23:04+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,201651000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,,2015-06-30,2015-08-07 16:23:04+00:00,totalnoncurrentliabilities,noncurrentemployeebenefitliabilities,Noncurrent Employee Benefit Liabilities,+,credit,usd,7856000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,,2015-06-30,2015-08-07 16:23:04+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,83493000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,,2015-06-30,2015-08-07 16:23:04+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,293000000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,,2015-06-30,2015-08-07 16:23:04+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,353559000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,,2015-06-30,2015-08-07 16:23:04+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,,2015-06-30,2015-08-07 16:23:04+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,,2015-06-30,2015-08-07 16:23:04+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,251087000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,,2015-06-30,2015-08-07 16:23:04+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,79716000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,,2015-06-30,2015-08-07 16:23:04+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-68248000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,,2015-06-30,2015-08-07 16:23:04+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-13530000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,,2015-06-30,2015-08-07 16:23:04+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,249025000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,,2015-06-30,2015-08-07 16:23:04+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,249025000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,,2015-06-30,2015-08-07 16:23:04+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,249025000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,,2015-06-30,2015-08-07 16:23:04+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,602584000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,,2015-09-30,2015-11-09 15:15:39+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,79462000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,,2015-09-30,2015-11-09 15:15:39+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,2963000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,,2015-09-30,2015-11-09 15:15:39+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,88306000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,,2015-09-30,2015-11-09 15:15:39+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,104668000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,,2015-09-30,2015-11-09 15:15:39+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,19887000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,,2015-09-30,2015-11-09 15:15:39+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,2249000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,,2015-09-30,2015-11-09 15:15:39+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,5894000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,,2015-09-30,2015-11-09 15:15:39+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,303429000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,,2015-09-30,2015-11-09 15:15:39+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,213686000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,,2015-09-30,2015-11-09 15:15:39+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,145726000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,,2015-09-30,2015-11-09 15:15:39+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,86814000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,,2015-09-30,2015-11-09 15:15:39+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,3644000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,,2015-09-30,2015-11-09 15:15:39+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,66569000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,,2015-09-30,2015-11-09 15:15:39+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,302753000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,,2015-09-30,2015-11-09 15:15:39+00:00,,totalassets,Total Assets,=,debit,usd,819868000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,,2015-09-30,2015-11-09 15:15:39+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,15129000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,,2015-09-30,2015-11-09 15:15:39+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,63311000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,,2015-09-30,2015-11-09 15:15:39+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,10908000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,,2015-09-30,2015-11-09 15:15:39+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,7253000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,,2015-09-30,2015-11-09 15:15:39+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,585000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,,2015-09-30,2015-11-09 15:15:39+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,2098000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,,2015-09-30,2015-11-09 15:15:39+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,99284000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,,2015-09-30,2015-11-09 15:15:39+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,344373000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,,2015-09-30,2015-11-09 15:15:39+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,3002000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,,2015-09-30,2015-11-09 15:15:39+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,12157000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,,2015-09-30,2015-11-09 15:15:39+00:00,totalnoncurrentliabilities,noncurrentemployeebenefitliabilities,Noncurrent Employee Benefit Liabilities,+,credit,usd,7465000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,,2015-09-30,2015-11-09 15:15:39+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,64850000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,,2015-09-30,2015-11-09 15:15:39+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,431847000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,,2015-09-30,2015-11-09 15:15:39+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,531131000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,,2015-09-30,2015-11-09 15:15:39+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,,2015-09-30,2015-11-09 15:15:39+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,,2015-09-30,2015-11-09 15:15:39+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,295687000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,,2015-09-30,2015-11-09 15:15:39+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,75546000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,,2015-09-30,2015-11-09 15:15:39+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-68410000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,,2015-09-30,2015-11-09 15:15:39+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-14086000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,,2015-09-30,2015-11-09 15:15:39+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,288737000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,,2015-09-30,2015-11-09 15:15:39+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,288737000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,,2015-09-30,2015-11-09 15:15:39+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,288737000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,,2015-09-30,2015-11-09 15:15:39+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,819868000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,,2016-03-31,2016-05-10 17:19:57+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,44193000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,,2016-03-31,2016-05-10 17:19:57+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,3000000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,,2016-03-31,2016-05-10 17:19:57+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,96112000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,,2016-03-31,2016-05-10 17:19:57+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,94080000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,,2016-03-31,2016-05-10 17:19:57+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,22492000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,,2016-03-31,2016-05-10 17:19:57+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,8079000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,,2016-03-31,2016-05-10 17:19:57+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,6055000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,,2016-03-31,2016-05-10 17:19:57+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,274011000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,,2016-03-31,2016-05-10 17:19:57+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,216902000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,,2016-03-31,2016-05-10 17:19:57+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,172882000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,,2016-03-31,2016-05-10 17:19:57+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,120726000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,,2016-03-31,2016-05-10 17:19:57+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,4104000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,,2016-03-31,2016-05-10 17:19:57+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,45588000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,,2016-03-31,2016-05-10 17:19:57+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,343300000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,,2016-03-31,2016-05-10 17:19:57+00:00,,totalassets,Total Assets,=,debit,usd,834213000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,,2016-03-31,2016-05-10 17:19:57+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,13843000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,,2016-03-31,2016-05-10 17:19:57+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,73650000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,,2016-03-31,2016-05-10 17:19:57+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,13534000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,,2016-03-31,2016-05-10 17:19:57+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,571000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,,2016-03-31,2016-05-10 17:19:57+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,101598000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,,2016-03-31,2016-05-10 17:19:57+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,373725000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,,2016-03-31,2016-05-10 17:19:57+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,2956000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,,2016-03-31,2016-05-10 17:19:57+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,17129000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,,2016-03-31,2016-05-10 17:19:57+00:00,totalnoncurrentliabilities,noncurrentemployeebenefitliabilities,Noncurrent Employee Benefit Liabilities,+,credit,usd,6700000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,,2016-03-31,2016-05-10 17:19:57+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,45187000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,,2016-03-31,2016-05-10 17:19:57+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,445697000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,,2016-03-31,2016-05-10 17:19:57+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,547295000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,,2016-03-31,2016-05-10 17:19:57+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,,2016-03-31,2016-05-10 17:19:57+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,,2016-03-31,2016-05-10 17:19:57+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,301315000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,,2016-03-31,2016-05-10 17:19:57+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,67264000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,,2016-03-31,2016-05-10 17:19:57+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-69169000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,,2016-03-31,2016-05-10 17:19:57+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-12492000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,,2016-03-31,2016-05-10 17:19:57+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,286918000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,,2016-03-31,2016-05-10 17:19:57+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,286918000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,,2016-03-31,2016-05-10 17:19:57+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,286918000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q1,,2016-03-31,2016-05-10 17:19:57+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,834213000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,,2016-06-30,2016-08-05 16:01:35+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,30675000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,,2016-06-30,2016-08-05 16:01:35+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,713000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,,2016-06-30,2016-08-05 16:01:35+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,100589000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,,2016-06-30,2016-08-05 16:01:35+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,93174000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,,2016-06-30,2016-08-05 16:01:35+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,22504000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,,2016-06-30,2016-08-05 16:01:35+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,1449000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,,2016-06-30,2016-08-05 16:01:35+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,7549000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,,2016-06-30,2016-08-05 16:01:35+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,256653000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,,2016-06-30,2016-08-05 16:01:35+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,222011000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,,2016-06-30,2016-08-05 16:01:35+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,170702000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,,2016-06-30,2016-08-05 16:01:35+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,117035000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,,2016-06-30,2016-08-05 16:01:35+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,0.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,,2016-06-30,2016-08-05 16:01:35+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,40105000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,,2016-06-30,2016-08-05 16:01:35+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,327842000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,,2016-06-30,2016-08-05 16:01:35+00:00,,totalassets,Total Assets,=,debit,usd,806506000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,,2016-06-30,2016-08-05 16:01:35+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,13082000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,,2016-06-30,2016-08-05 16:01:35+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,72479000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,,2016-06-30,2016-08-05 16:01:35+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,10317000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,,2016-06-30,2016-08-05 16:01:35+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,436000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,,2016-06-30,2016-08-05 16:01:35+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,6401000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,,2016-06-30,2016-08-05 16:01:35+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,102715000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,,2016-06-30,2016-08-05 16:01:35+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,370798000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,,2016-06-30,2016-08-05 16:01:35+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,2101000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,,2016-06-30,2016-08-05 16:01:35+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,20166000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,,2016-06-30,2016-08-05 16:01:35+00:00,totalnoncurrentliabilities,noncurrentemployeebenefitliabilities,Noncurrent Employee Benefit Liabilities,+,credit,usd,6627000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,,2016-06-30,2016-08-05 16:01:35+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,41167000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,,2016-06-30,2016-08-05 16:01:35+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,440859000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,,2016-06-30,2016-08-05 16:01:35+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,543574000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,,2016-06-30,2016-08-05 16:01:35+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,,2016-06-30,2016-08-05 16:01:35+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,,2016-06-30,2016-08-05 16:01:35+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,304299000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,,2016-06-30,2016-08-05 16:01:35+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,45996000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,,2016-06-30,2016-08-05 16:01:35+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-69225000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,,2016-06-30,2016-08-05 16:01:35+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-18138000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,,2016-06-30,2016-08-05 16:01:35+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,262932000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,,2016-06-30,2016-08-05 16:01:35+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,262932000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,,2016-06-30,2016-08-05 16:01:35+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,262932000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q2,,2016-06-30,2016-08-05 16:01:35+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,806506000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,,2016-09-30,2016-11-09 16:40:12+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,44756000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,,2016-09-30,2016-11-09 16:40:12+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,242000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,,2016-09-30,2016-11-09 16:40:12+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,126898000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,,2016-09-30,2016-11-09 16:40:12+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,201901000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,,2016-09-30,2016-11-09 16:40:12+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,23060000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,,2016-09-30,2016-11-09 16:40:12+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,1784000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,,2016-09-30,2016-11-09 16:40:12+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,5607000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,,2016-09-30,2016-11-09 16:40:12+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,404248000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,,2016-09-30,2016-11-09 16:40:12+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,376121000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,,2016-09-30,2016-11-09 16:40:12+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,241402000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,,2016-09-30,2016-11-09 16:40:12+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,179620000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,,2016-09-30,2016-11-09 16:40:12+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,3839000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,,2016-09-30,2016-11-09 16:40:12+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,52853000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,,2016-09-30,2016-11-09 16:40:12+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,477714000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,,2016-09-30,2016-11-09 16:40:12+00:00,,totalassets,Total Assets,=,debit,usd,1258083000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,,2016-09-30,2016-11-09 16:40:12+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,35841000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,,2016-09-30,2016-11-09 16:40:12+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,127378000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,,2016-09-30,2016-11-09 16:40:12+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,14782000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,,2016-09-30,2016-11-09 16:40:12+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,4162000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,,2016-09-30,2016-11-09 16:40:12+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,380000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,,2016-09-30,2016-11-09 16:40:12+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,182543000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,,2016-09-30,2016-11-09 16:40:12+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,606112000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,,2016-09-30,2016-11-09 16:40:12+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,2101000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,,2016-09-30,2016-11-09 16:40:12+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,45287000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,,2016-09-30,2016-11-09 16:40:12+00:00,totalnoncurrentliabilities,noncurrentemployeebenefitliabilities,Noncurrent Employee Benefit Liabilities,+,credit,usd,19853000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,,2016-09-30,2016-11-09 16:40:12+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,64189000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,,2016-09-30,2016-11-09 16:40:12+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,737542000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,,2016-09-30,2016-11-09 16:40:12+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,920085000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,,2016-09-30,2016-11-09 16:40:12+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,,2016-09-30,2016-11-09 16:40:12+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,,2016-09-30,2016-11-09 16:40:12+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,398779000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,,2016-09-30,2016-11-09 16:40:12+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,22571000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,,2016-09-30,2016-11-09 16:40:12+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-69297000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,,2016-09-30,2016-11-09 16:40:12+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-14055000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,,2016-09-30,2016-11-09 16:40:12+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,337998000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,,2016-09-30,2016-11-09 16:40:12+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,337998000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,,2016-09-30,2016-11-09 16:40:12+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,337998000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,,2016-09-30,2016-11-09 16:40:12+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1258083000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,,2017-03-31,2017-05-09 21:43:16+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,35193000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,,2017-03-31,2017-05-09 21:43:16+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,243000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,,2017-03-31,2017-05-09 21:43:16+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,139705000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,,2017-03-31,2017-05-09 21:43:16+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,174043000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,,2017-03-31,2017-05-09 21:43:16+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,26626000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,,2017-03-31,2017-05-09 21:43:16+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,2943000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,,2017-03-31,2017-05-09 21:43:16+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,6397000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,,2017-03-31,2017-05-09 21:43:16+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,385150000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,,2017-03-31,2017-05-09 21:43:16+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,360282000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,,2017-03-31,2017-05-09 21:43:16+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,230886000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,,2017-03-31,2017-05-09 21:43:16+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,164162000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,,2017-03-31,2017-05-09 21:43:16+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,523000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,,2017-03-31,2017-05-09 21:43:16+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,22526000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,,2017-03-31,2017-05-09 21:43:16+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,418097000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,,2017-03-31,2017-05-09 21:43:16+00:00,,totalassets,Total Assets,=,debit,usd,1163529000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,,2017-03-31,2017-05-09 21:43:16+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,34206000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,,2017-03-31,2017-05-09 21:43:16+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,108894000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,,2017-03-31,2017-05-09 21:43:16+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,19516000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,,2017-03-31,2017-05-09 21:43:16+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,3627000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,,2017-03-31,2017-05-09 21:43:16+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,769000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,,2017-03-31,2017-05-09 21:43:16+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,167012000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,,2017-03-31,2017-05-09 21:43:16+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,607246000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,,2017-03-31,2017-05-09 21:43:16+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,3894000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,,2017-03-31,2017-05-09 21:43:16+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,36505000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,,2017-03-31,2017-05-09 21:43:16+00:00,totalnoncurrentliabilities,noncurrentemployeebenefitliabilities,Noncurrent Employee Benefit Liabilities,+,credit,usd,17993000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,,2017-03-31,2017-05-09 21:43:16+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,34080000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,,2017-03-31,2017-05-09 21:43:16+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,699718000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,,2017-03-31,2017-05-09 21:43:16+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,866730000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,,2017-03-31,2017-05-09 21:43:16+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,,2017-03-31,2017-05-09 21:43:16+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,,2017-03-31,2017-05-09 21:43:16+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,403968000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,,2017-03-31,2017-05-09 21:43:16+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-3532000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,,2017-03-31,2017-05-09 21:43:16+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-71312000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,,2017-03-31,2017-05-09 21:43:16+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-32325000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,,2017-03-31,2017-05-09 21:43:16+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,296799000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,,2017-03-31,2017-05-09 21:43:16+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,296799000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,,2017-03-31,2017-05-09 21:43:16+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,296799000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q1,,2017-03-31,2017-05-09 21:43:16+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1163529000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,,2017-06-30,2017-08-09 14:33:32+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,42227000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,,2017-06-30,2017-08-09 14:33:32+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,300000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,,2017-06-30,2017-08-09 14:33:32+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,139342000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,,2017-06-30,2017-08-09 14:33:32+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,186409000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,,2017-06-30,2017-08-09 14:33:32+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,26138000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,,2017-06-30,2017-08-09 14:33:32+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,5532000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,,2017-06-30,2017-08-09 14:33:32+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,3964000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,,2017-06-30,2017-08-09 14:33:32+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,403912000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,,2017-06-30,2017-08-09 14:33:32+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,362036000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,,2017-06-30,2017-08-09 14:33:32+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,238702000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,,2017-06-30,2017-08-09 14:33:32+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,168382000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,,2017-06-30,2017-08-09 14:33:32+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,563000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,,2017-06-30,2017-08-09 14:33:32+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,68779000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,,2017-06-30,2017-08-09 14:33:32+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,476426000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,,2017-06-30,2017-08-09 14:33:32+00:00,,totalassets,Total Assets,=,debit,usd,1242374000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,,2017-06-30,2017-08-09 14:33:32+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,452372000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,,2017-06-30,2017-08-09 14:33:32+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,116919000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,,2017-06-30,2017-08-09 14:33:32+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,20188000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,,2017-06-30,2017-08-09 14:33:32+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,2222000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,,2017-06-30,2017-08-09 14:33:32+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,958000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,,2017-06-30,2017-08-09 14:33:32+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,592659000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,,2017-06-30,2017-08-09 14:33:32+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,195591000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,,2017-06-30,2017-08-09 14:33:32+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,3068000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,,2017-06-30,2017-08-09 14:33:32+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,34782000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,,2017-06-30,2017-08-09 14:33:32+00:00,totalnoncurrentliabilities,noncurrentemployeebenefitliabilities,Noncurrent Employee Benefit Liabilities,+,credit,usd,18412000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,,2017-06-30,2017-08-09 14:33:32+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,80839000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,,2017-06-30,2017-08-09 14:33:32+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,332692000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,,2017-06-30,2017-08-09 14:33:32+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,925351000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,,2017-06-30,2017-08-09 14:33:32+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,,2017-06-30,2017-08-09 14:33:32+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,,2017-06-30,2017-08-09 14:33:32+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,408370000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,,2017-06-30,2017-08-09 14:33:32+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-13777000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,,2017-06-30,2017-08-09 14:33:32+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-71380000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,,2017-06-30,2017-08-09 14:33:32+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-6190000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,,2017-06-30,2017-08-09 14:33:32+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,317023000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,,2017-06-30,2017-08-09 14:33:32+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,317023000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,,2017-06-30,2017-08-09 14:33:32+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,317023000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2017.0,Q2,,2017-06-30,2017-08-09 14:33:32+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1242374000.0
